Glenn H Nussdorf has bought ORGO on 5 days since Sep 2019
Director at Organogenesis Holdings Inc.
SEC CIK 0001244191 · Filings on SEC.gov ↗
Glenn H Nussdorf's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
9 filings since Sep 2019, newest first
Organogenesis Holdings Inc.
Director
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
Organogenesis Holdings Inc.
Director and 10% owner
About Glenn H Nussdorf
Glenn H. Nussdorf is a 70-year-old business executive serving as Director at Organogenesis Holdings Inc. (ORGO) since 2003. He is not classified as an independent director and holds a significant beneficial ownership stake of approximately 9.4% to 11.7 million shares, valued at around $48 million as of late 2025, making him a 10% owner.( Nussdorf brings expertise as Chief Executive Officer of Quality King Distributors, Inc. and its subsidiary QK Healthcare, Inc. since 1999, focusing on distribution in health and beauty care (HBC) and prescription products, and has been a director and major stockholder at Parlux Holdings, Inc. since 2017.(
Nussdorf has been active in recent insider trading at ORGO, including selling 306,300 shares for $1.59 million between November 24-26, 2025, and 200,000 shares on December 16, 2025.( He maintains strong board attendance (≥75% in 2024) but is involved in related-party transactions, such as ORGO leasing facilities from entities he controls.( Previously part of a significant stockholder group that influenced governance until its agreement terminated on March 10, 2025, his long tenure aligns shareholder interests through substantial ownership.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.